InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 11/25/2019 3:46:10 PM

Monday, November 25, 2019 3:46:10 PM

Post# of 232
News: $MDCO A 45% Premium: Here's Why The Medicines Company Is Worth More to Novartis Than It Was to You

It turns out the rumors were true. Novartis (NYSE: NVS) is buying The Medicines Company (NASDAQ: MDCO) for $85 per share. That's a 45% premium above the closing price prior to the acquisition rumor being published. Investors kicking themselves for not seeing the higher potential valu...

Find out more MDCO - A 45% Premium: Here's Why The Medicines Company Is Worth More to Novartis Than It Was to You